12-11-2024
Source: EGX
Company Name : Macro Group Pharmaceuticals -Macro Capital
ISIN Code : EGS7D971C011
Currency : EGP
F/S Standalone Period : From 01/01/2024 To 30/09/2024
Net Loss : 64,442,930
F/S Standalone Period : From 01/01/2023 To 30/09/2023
Net Comparative Profit : 100,348,097
Audit Status : Reviewed
Source : Macro Group Pharmaceuticals -Macro Capital
EGX30
Advancing : Declining 0 : 1
shares
| Sector Name | T/O (EGP Mn) | Mkt % |
| Financial Services and Electronic Payments | 847.08 | 21.49 |
| Real Estate and Hotels | 814.28 | 20.66 |
| Industrial, Construction and Materials | 790.09 | 20.05 |
| Banks | 353.14 | 8.96 |
| Chemicals | 242.10 | 6.14 |
| Consumer Discretionary | 218.59 | 5.55 |
| Food and Beverage | 177.76 | 4.51 |
| Other | 133.54 | 3.39 |
| Healthcare and Pharmaceuticals | 130.28 | 3.31 |
| Transportation, Shipping and Logistics | 101.77 | 2.58 |
| Energy | 67.94 | 1.72 |
| Technology, Media and Telecom | 38.82 | 0.98 |
| Education | 25.46 | 0.65 |